ThaiPR.NET https://www.thaipr.net/location/seoul Press Release Distribution Center of Thailand Thu, 30 Apr 2026 17:24:39 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[GemVax & KAEL reports further positive data from GV1001 Phase II Alzheimer’s Disease trial]]> https://www.thaipr.net/en/health_en/3003574 Tue, 24 Nov 2020 09:35:00 +0700 health_en https://www.thaipr.net/en/health_en/3003574 GemVax & KAEL Co., Ltd.) a clinical stage company developing a novel peptide drug based on telomerase modification has released further positive data at the Korean Dementia Association’s Fall Conference from a Phase II trial in Alzheimer’s disease of lead candidate GV1001. Previously the company announced GV1001 was well tolerated and safe and the primary […]

The post GemVax & KAEL reports further positive data from GV1001 Phase II Alzheimer’s Disease trial appeared first on ThaiPR.NET.

]]>